LEMAITRE VASCULAR, INC. (LMAT) Return on equity 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
14.7%FY2025 · since FY2016: 12.1% → 14.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 14.7% | +1.6 pp |
| FY2024 | 13.0% | +2.9 pp |
| FY2023 | 10.1% | +2.4 pp |
| FY2022 | 7.7% | -2.9 pp |
| FY2021 | 10.6% | -1.7 pp |
| FY2020 | 12.3% | +0.2 pp |
| FY2019 | 12.1% | -5.5 pp |
| FY2018 | 17.6% | +2.0 pp |
| FY2017 | 15.6% | +3.5 pp |
| FY2016 | 12.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice